title: Evolving role of growth factors in the renal response to acute and chronic disease.
abstract: The roles of growth factors in the pathogenesis of various forms of acute and chronic renal disease are largely putative. Nevertheless, there is a growing body of information that links specific growth factors to particular forms of renal injury. In all instances, it is supposed that such associations are not necessarily unique and that multiple cytokines probably interact to determine the pattern of injury or the regenerative response to such injury. Regeneration of tubular epithelium after acute tubular necrosis involves upregulation of the epidermal growth factor (EGF) receptor. Early studies of exogenously administered EGF indicate that the severity and duration of renal failure may be attenuated by this growth factor. Thus far, the observed responses have been limited and the role of EGF as a therapeutic agent requires more study. The mechanism of generation of tubulointerstitial injury in most forms of renal disease is difficult to understand. Early in vitro studies of growth factor production by tubular cells (in the absence of any infiltrating cells) indicate that platelet-derived growth factor produced by the medullary collecting duct is mitogenic for renal medullary fibroblasts, suggesting a paracrine growth system in this region of the kidney. Insulin-like growth factor I has also been shown to be produced by collecting duct cells. Its production is increased by EGF, and its association with certain forms of renal hypertrophy, i.e., diabetes and hypersomatotrophic states, implies its participation in the hypertrophic growth response. Platelet-derived growth factor is a potent mitogen for glomerular mesangial cells, and its production is regulated by a variety of cytokines.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Medicine, University College and Middlesex School of Medicine, London, England.
authors.forename: L G
authors.initials: LG
authors.lastname: Fine
authors.forename: M R
authors.initials: MR
authors.lastname: Hammerman
authors.forename: H E
authors.initials: HE
authors.lastname: Abboud
mesh_terms: D000818:Animals; D002455:Cell Division / Q000187:drug effects; D004815:Epidermal Growth Factor / Q000502:physiology; D005355:Fibrosis; D005920:Glomerular Mesangium / Q000378:metabolism; D006133:Growth Substances / Q000502:physiology*; D006801:Humans; D006984:Hypertrophy; D007334:Insulin-Like Growth Factor I / Q000502:physiology; D007668:Kidney / Q000473:pathology / Q000502:physiology; D007674:Kidney Diseases / Q000503:physiopathology*; D007678:Kidney Glomerulus / Q000473:pathology; D009392:Nephrectomy; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology; D051381:Rats; D012038:Regeneration; D016212:Transforming Growth Factor beta / Q000502:physiology
chemical_list: D006133:Growth Substances; D010982:Platelet-Derived Growth Factor; D016212:Transforming Growth Factor beta; D004815:Epidermal Growth Factor; D007334:Insulin-Like Growth Factor I